Nationwide Recall Issued for Injectable Glutathione, Myer’s Cocktail, and Tri-Immune Boost Products

Centric Compounding has announced a nationwide voluntary recall of six lots of injectable products after an ingredient used in their preparation was found to contain elevated levels of endotoxins. The recalled products include glutathione, Myer’s Cocktail and Tri-Immune Boost injections.

The U.S. Food and Drug Administration (FDA) published the recall announcement on Sept. 13, 2026. According to the notice, Centric Compounding received nine reports involving symptoms potentially associated with the recalled injectable products.

Reported symptoms included fever, chills, chest pain, nausea, vomiting, headache and a general feeling of discomfort or illness.

The Houston-based compounding company is asking consumers to immediately stop using affected products and discard any recalled vials. The company is also contacting customers and distributors and arranging replacements for recalled products.

Which Injectable Products Are Being Recalled?

The nationwide recall involves three injectable products manufactured by Centric Compounding. Each product was packaged in a 30-milliliter multidose vial.

The recalled products are:

• Glutathione 200 mg/mL
• Myer’s Cocktail
• Tri-Immune Boost

Six specific lots are included in the recall.

For Glutathione 200 mg/mL, the affected lots are:

• Lot 062326, with a beyond-use date of Aug. 7, 2026
• Lot 070826, with a beyond-use date of Aug. 22, 2026
• Lot 072726, with a beyond-use date of Sept. 25, 2026

For Myer’s Cocktail, the recalled lots are:

• Lot 070226, with a beyond-use date of Aug. 16, 2026
• Lot 072126, with a beyond-use date of Sept. 4, 2026

The recall also includes:

• Tri-Immune Boost, lot 071626, with a beyond-use date of Aug. 30, 2026

Consumers who have these products should check the lot number and beyond-use date on the vial before using them. If the product is part of one of the recalled lots, it should not be used.

Why Were the Injections Recalled?

Centric Compounding said the affected preparations were made using a glutathione active pharmaceutical ingredient that contained elevated endotoxin levels.

Endotoxins are substances associated with certain bacteria. When present in injectable products, elevated levels can potentially trigger significant inflammatory reactions in the body.

According to the FDA recall announcement, injectable products containing elevated endotoxin levels could potentially result in serious medical events. The notice identifies possible complications including fever, low blood pressure, inflammatory reactions, anaphylactic shock and death.

Because these products are administered by injection, concerns about contamination or elevated endotoxin levels can be particularly important. Injectable medicines and compounded preparations are introduced directly into the body, making product quality and sterility critical considerations.

Symptoms Reported After Use

Centric Compounding reported receiving nine reports involving symptoms that may have occurred after use of the recalled products.

The reported symptoms included:

• Fever
• Chills
• Chest pain
• Nausea
• Vomiting
• Headache
• A general feeling of illness or discomfort

The presence of these reports does not by itself establish that every reported symptom was caused by the recalled products. However, the reports were part of the circumstances surrounding the nationwide recall.

Consumers who have used one of the recalled products and subsequently developed concerning symptoms should contact a physician or another qualified health care professional.

Anyone experiencing a severe or potentially life-threatening reaction should seek emergency medical attention.

What Should Consumers Do With Recalled Products?

Centric Compounding is instructing consumers to stop using the affected products and discard recalled vials.

The company said it is contacting distributors and customers about the recall. It is also arranging replacement products for those affected by the recall.

Consumers who are unsure whether their vial is included should compare the product name, lot number and beyond-use date with the information provided in the official recall notice.

Patients should also speak with their health care provider if they have questions about stopping a treatment or replacing a recalled injectable product.

How to Report a Reaction

The FDA encourages consumers and health care professionals to report adverse reactions and product quality concerns through its MedWatch program.

Reports can be submitted through the FDA's MedWatch reporting system online, by mail or by fax.

Reporting suspected adverse events can help regulators identify potential safety problems and determine whether additional action is necessary.

Consumers with questions specifically about the Centric Compounding recall can contact the company at 833-777-6664 or info@centriccompounding.com. The company lists its customer service hours as Monday through Friday, from 9 a.m. to 5 p.m. Central Time.

What Are Glutathione, Myer’s Cocktail and Tri-Immune Boost?

Glutathione is a naturally occurring antioxidant that is involved in several processes in the body. Injectable glutathione is used in some health and wellness settings, although its uses and evidence can vary depending on the intended purpose.

A Myer’s Cocktail is an intravenous or injectable preparation that may contain combinations of vitamins and minerals. Formulations can vary between providers and compounding pharmacies.

Tri-Immune Boost is another compounded injectable product marketed for wellness and immune support.

Centric Compounding described the recalled products as being intended to support areas such as immunity, fatigue and general wellness.

Because compounded medications can be prepared for specific patients or uses, consumers should rely on their prescribing health care professional and the official recall information when determining what to do with a recalled product.

Injectable Product Recalls Highlight the Importance of Product Safety

The Centric Compounding recall is the latest in a series of drug safety actions involving medications and compounded products in the United States.

In July 2026, the FDA announced a nationwide recall involving certain levothyroxine sodium tablets distributed by Major Pharmaceuticals. That recall was initiated because of insufficient potency.

Levothyroxine is commonly prescribed to treat an underactive thyroid, also known as hypothyroidism. The FDA classified that recall as a Class II recall, a category generally used when exposure to a product may cause temporary or medically reversible health consequences, or when serious adverse effects are considered unlikely.

The two recalls involve different products and different quality concerns. The levothyroxine recall involved insufficient potency, while the Centric Compounding recall involves elevated endotoxin levels in an ingredient used to prepare injectable products.

What Consumers Should Know

Consumers who have received glutathione, Myer’s Cocktail or Tri-Immune Boost from Centric Compounding should check their product carefully against the recalled lot information.

Anyone with an affected vial should stop using it and follow the company's instructions for disposal and replacement.

Patients should not make changes to prescribed medical treatment without discussing them with an appropriate health care professional. For people who have experienced symptoms after using a recalled injectable product, medical advice can help determine whether further evaluation is appropriate.

The FDA and Centric Compounding are continuing to provide information about the recall. Consumers should consult the official FDA recall notice for the most current instructions and product details.